Vanderbilt Health and Eli Lilly are developing an AI agent to speed Alzheimer's disease treatment, with plans for radiology-focused AI tools.
Key Details
- 1Vanderbilt Health received a $600,000 grant from Eli Lilly to build an AI triage agent for Alzheimer's care in the EHR system.
- 2The AI tool will streamline referrals, summarize charts, flag missing details, and prioritize cases, aiming to reduce wait times for monoclonal antibody treatment.
- 3The project will be piloted with data from over 5,300 patients at Vanderbilt Health, targeting reduced time from diagnosis to infusion.
- 4Plans include a second AI agent to analyze MRI images and generate Alzheimer's safety reports for radiologists, and a third to support insurance authorization.
- 5Outcomes will be measured by reduced delays across the dementia care pathway.
Why It Matters
The integration of AI triage and radiology-focused agents aims to address bottlenecks in Alzheimer's care, supporting faster and more accurate treatment. Success here could set a model for scalable, AI-enhanced workflows across radiology and neurology.
Source
EurekAlert
Related News
•EurekAlert
USC AI Model Maps Local Brain Aging on MRI to Aid Dementia Research
USC researchers developed an AI model that uses MRI to produce detailed maps of local brain aging, revealing patterns linked to cognitive decline and Alzheimer's disease.
•EurekAlert
AI Pathology Tool SÉMIL Improves Stage II Bowel Cancer Risk Assessment
A La Trobe University-developed AI tool accurately predicts relapse risk in stage II bowel cancer using digital pathology images and descriptions.
•EurekAlert
AI Tool Predicts Which Rectal Cancer Patients Benefit from Intensive Therapy
UCL researchers developed an AI that analyzes biopsy slides to identify rectal cancer patients who benefit from adding irinotecan to standard chemoradiotherapy.